Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,081 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nanoplasmonic amplification in microfluidics enables accelerated colorimetric quantification of nucleic acid biomarkers from pathogens.
AbdElFatah T, Jalali M, Yedire SG, I Hosseini I, Del Real Mata C, Khan H, Hamidi SV, Jeanne O, Siavash Moakhar R, McLean M, Patel D, Wang Z, McKay G, Yousefi M, Nguyen D, Vidal SM, Liang C, Mahshid S. AbdElFatah T, et al. Among authors: liang c. Nat Nanotechnol. 2023 Aug;18(8):922-932. doi: 10.1038/s41565-023-01384-5. Epub 2023 Jun 1. Nat Nanotechnol. 2023. PMID: 37264088
USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation.
Torre S, Polyak MJ, Langlais D, Fodil N, Kennedy JM, Radovanovic I, Berghout J, Leiva-Torres GA, Krawczyk CM, Ilangumaran S, Mossman K, Liang C, Knobeloch KP, Healy LM, Antel J, Arbour N, Prat A, Majewski J, Lathrop M, Vidal SM, Gros P. Torre S, et al. Among authors: liang c. Nat Immunol. 2017 Jan;18(1):54-63. doi: 10.1038/ni.3581. Epub 2016 Oct 10. Nat Immunol. 2017. PMID: 27721430
Erratum: USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation.
Torre S, Polyak MJ, Langlais D, Fodil N, Kennedy JM, Radovanovic I, Berghout J, Leiva-Torres GA, Krawczyk CM, Ilangumaran S, Mossman K, Liang C, Knobeloch KP, Healy LM, Antel J, Arbour N, Prat A, Majewski J, Lathrop M, Vidal SM, Gros P. Torre S, et al. Among authors: liang c. Nat Immunol. 2016 Nov 16;17(12):1479. doi: 10.1038/ni1216-1479c. Nat Immunol. 2016. PMID: 27849203 No abstract available.
Clinical outcomes and risk factors for mortality in recipients with carbapenem-resistant gram-negative bacilli infections after kidney transplantation treated with ceftazidime-avibactam: a retrospective study.
Zhang F, Li P, Zhong J, Ding H, Liao G, Liang C. Zhang F, et al. Among authors: liang c. Front Cell Infect Microbiol. 2024 May 8;14:1404404. doi: 10.3389/fcimb.2024.1404404. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38779560 Free PMC article.
10,081 results
You have reached the last available page of results. Please see the User Guide for more information.